Join us for a multidisciplinary review of early stage non-small cell lung cancer (NSCLC) presented by the Temple Health Office for Continuing Medical Education, Fox Chase Cancer Center, and the Temple Lung Center—nationally recognized researchers and clinicians specializing in thoracic surgery, medical oncology, radiation oncology, radiology, pulmonology, and nursing.

The program will focus on the latest research and strategies for optimally managing early stage NSCLC patients, including detection, imaging, diagnosis, staging, and treatment.

DETAILS:

Saturday, November 4, 2023
8:00 am – 8:30 am Check-in and Breakfast
8:30 am – 4:00 pm CME Program

Philadelphia Marriott Old City
One Dock Street, Philadelphia, PA 19106

Program Directors:

Joseph Friedberg, MD, FACS
Thoracic Surgeon-in-Chief, Temple University Health System
Vice Chair, Surgical Services,
Department of Thoracic Medicine and Surgery
Co-Director, Temple-Fox Chase Cancer Center
Mesothelioma and Pleural Disease Program
Professor, Thoracic Medicine and Surgery,
Lewis Katz School of Medicine at Temple University
Professor, Department of Surgical Oncology, Fox Chase Cancer Center

Gerard Criner, MD, FACP, FACCP
Chair and Professor, Thoracic Medicine and Surgery,
Lewis Katz School of Medicine at Temple University
Director, Temple Lung Center

Sukhmani Kaur Padda, MD
Professor, Department of Hematology/Oncology, Fox Chase Cancer Center
Vice Chair and Professor of Medical Oncology,
Fox Chase Cancer Center at Temple University Hospital

Melissa Culligan, RN, MS, PhD Candidate
Co-Director, Temple-Fox Chase Cancer Center
Mesothelioma and Pleural Disease Program

Presenters and Topics:

Session One - Moderator: David Manoff, MD
“Houston, We Have a Problem” A Rapid-Fire Review of Finding, Diagnosing, and Staging Non-Small Cell Lung Cancer (NSCLC)

• Lung Cancer Screening 2023—Who, How, Why, What’s Next?
  Gerard Criner, MD, FACP, FACCP
• Review of the Current NSCLC Staging System—Getting Us on the Same Page
  Cherie Erkmen, MD
• 2023 CT Radiographic Imaging for Lung Nodules and Clinical Staging of NSCLC—Artificial Intelligence vs. Real Intelligence
  Hillel Maresky, MD
• 2023 Bronchoscopic Diagnosis of Lung Nodules—What’s Possible, What’s Not, and How It’s Done
  Christopher Manley, MD
• 2023 Percutaneous Diagnosis of Lung Nodules—What We Can Hit, What We Can’t
• Maruti Kumaran, MD, MBBS, FRCR
  2023 Bronchoscopic Staging of the Mediastinum—When to Stick It, When Not; How Sensitive and Accurate Are We?
  Rohit Kumar, MD
• The Dying Art of Mediastinoscopy—When, if Ever?
  Stacey Su, MD, FACS
• The Vexing and Ever-Increasing Problem of Ground Glass Opacities
  Whitney Burrows, MD
• “So You Got a Biopsy; Now What?”—Lung Cancer Pathology 101, for the Interested but Uninformed
  Douglas Flieder, MD

SESSION TWO - Moderator: Jessica Bauman, MD
“Now What?” Treating the Lung Cancer Patient

• Thoracic Surgery 101 (For Those Unfortunate Enough Not to be Thoracic Surgeons)
  Charles Bakhos, MD, MBA, MS, FACS
• Getting the Patient from the Office to the Operating Room—The Nuts and Bolts and Tips, Tricks, and Advice
  Kaitlyn Gregory, DNP, CRNP, FNP-BC
• Quality of Life and Other Considerations—Thinking About the Whole Patient
  Melissa Culligan, RN, MS, PhD Candidate
• Radiation for Lung Cancer 101—Where Are We in 2023?
  Curtis Miyamoto, MD
• Adjuvant and Neoadjuvant Treatment of Lung Cancer: The Revolution and What You Need to Know
  Martin Edelman, MD

SESSION THREE - Moderator: Joseph Friedberg, MD, FACS
“But Wait, There’s More” Additional Updates to Add to Your Arsenal

• Exciting Basic Science and Translational Lung Cancer Research—For English Majors and Surgeons
  Margie Clapper, PhD
• Current Clinical Trials Everyone Should Know About
  Jessica Bauman, MD
• Mesothelioma: Not Lung Cancer but Seems to Get Lumped in—Where Are We in 2023?
  Joseph Friedberg, MD, FACS
• Liquid Biopsies for Lung Cancer—What Are They, What Role Should They Play, and Does Anyone Even Pay for Them?
  J. Nicholas Bodor, MD, PhD, MPH

SESSION FOUR - Moderator: Sukhmani Kaur Padda, MD
Tumor Board Case Presentations Putting it All Together

• Early Stage Disease in High-risk Patients (Poor Pulmonary Function, Prior Lung Transplant, Multiple Comorbidities)
  Danish Ahmad, MD; Jessica Bauman, MD; Cherie Erkmen, MD; Sameera Kumar, MD
• Complex Cancer in Low-risk Patients (T4 Tumors)
  Danish Ahmad, MD; Jessica Bauman, MD; Whitney Burrows, MD; Sameera Kumar, MD
• Bilateral Nodules (Both Solid and GGO)
  Jessica Bauman, MD; Whitney Burrows, MD; Rohit Kumar, MD; Sameera Kumar, MD
• Stage 3a Disease—The Persistent Grey Zone in Lung Cancer Treatment
  Jessica Bauman, MD; Rohit Kumar, MD; Sameera Kumar, MD; Stacey Su, MD, FACS